For example, Pasupuleti et al. demonstrated that metabolic and genetic factors act synergistically, with obesity-induced inflammation cooperating with CHIP-associated mutations, such as TET2, to accelerate both the onset of leukemogenesis and atherosclerotic CVD [30]. The gene discussed is STUB1; the disease is obesity disorder.